» Articles » PMID: 17237728

Energy Expenditure, Inflammation, and Oxidative Stress in Steady-state Adolescents with Sickle Cell Anemia

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 2007 Jan 24
PMID 17237728
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Sickle cell anemia (HbSS) is characterized by hypermetabolism, chronic inflammation, and increased oxidative stress, but the relationship between these factors is undefined. In this study, we examined indicators of inflammatory process and markers of oxidative damage and their impact on resting energy expenditure (REE) in stable HbSS adolescents (n = 35) and healthy controls carrying normal hemoglobin genotype (HbAA) (n = 39). C-reactive protein (CRP), white blood cell (WBC) count, and proinflammatory cytokines were measured as markers of inflammation and 2,3-dinor-5,6-dihydro-15-F2t-isoprostane (F2-IsoPM) as a marker of oxidative stress. REE was measured by indirect calorimetry. WBC counts (11.90 +/- 5.3 x10/muL versus 5.6 +/- 1.9 x10/muL; p < 0.001), serum CRP (9.1 +/- 11.0 mug/mL versus 0.4 +/- 0.7 mug/mL; p < 0.001) and serum IL-8 (7.5 +/- 4.4 pg/mL versus 5.5 +/- 4.8 pg/mL; p = 0.011) were higher in HbSS than HbAA, suggesting an anti-inflammatory response in HbSS. Higher urinary F2-IsoPM in HbSS (1.2 +/- 0.4 versus 0.7 +/- 0.3 ng/mg creatinine; p < 0.001) indicates increased oxidative stress. Fat free mass (FFM), hemoglobin (Hgb), interleukin (IL)-8, and F2-IsoPM were independent predictors of REE in HbSS (overall r = 0.778; p < 0.001). Low-grade inflammation and increased oxidative stress are present in adolescents with HbSS in the absence of acute crisis, and their markers are correlated with elevated REE.

Citing Articles

Effect of Unmetabolized Folic Acid on Immunoinflammatory Markers in Sickle Cell Disease Patients Taking Folic Acid Supplementation.

Chandrakar D, Patel S, Wasnik P, Mohapatra E, Nanda R, Shah S Indian J Clin Biochem. 2024; 39(4):557-564.

PMID: 39346717 PMC: 11436518. DOI: 10.1007/s12291-024-01204-0.


Indicators for Osteomyelitis in Children With Sickle Cell Disease Admitted With Vaso-Occlusive Crises.

Tashkandi D, Hanafy E, Alotaibi N, Abuharfel D, Alnijaidi A, Banjar A Cureus. 2024; 16(8):e68265.

PMID: 39238724 PMC: 11375391. DOI: 10.7759/cureus.68265.


Evaluation of peripheral blood inflammatory biomarkers in sickle cell disease with and without retinopathy.

Ozer O, Dogan L, Baysal Z, Basir H, Ciftci A, Eroz P Graefes Arch Clin Exp Ophthalmol. 2024; 262(12):3787-3796.

PMID: 38976013 PMC: 11608169. DOI: 10.1007/s00417-024-06569-9.


Cardiovascular consequences of sickle cell disease.

Palomarez A, Jha M, Medina Romero X, Horton R Biophys Rev (Melville). 2024; 3(3):031302.

PMID: 38505276 PMC: 10903381. DOI: 10.1063/5.0094650.


Nutritional studies in patients with β-thalassemia major: A short review.

Soliman A, Yassin M, Alyafei F, Alaaraj N, Hamed N, Osman S Acta Biomed. 2023; 94(3):e2023187.

PMID: 37326258 PMC: 10308461. DOI: 10.23750/abm.v94i3.14732.